• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Medicine: Department of Biomedical Informatics
  • UAMS Health
  • Jobs
  • Giving
  • About Us
    • Employment
    • News
    • Links
    • Department Intranet
  • Faculty
    • Primary Faculty
    • Secondary Faculty
    • Adjunct Faculty
  • Staff
  • Education
    • Admission Information
    • Student Funding Opportunities
    • Graduate Programs
    • Current Course Offerings
    • DBMI FAQs
    • Research & Application Seminar
    • Recorded Sessions for CME Credit
  • INBRE
    • INBRE Bioinformatics Core Support Request Form
  • Research Labs
    • Publications
    • Arkansas Center for Genomic & Ecological Medicine (ArC-GEM)
    • Arkansas Clinical Data Repository (AR-CDR)
    • Biomedical Ontologies Arkansas (BOAR)
  • Clinical Informatics Fellowship
    • Fellowship Overview
    • Training Sites
    • Faculty
    • Current Fellows
    • Welcome to Little Rock!
  • Databases
  • Diversity, Equity, and Inclusion
    • About DBMI-DEI
    • DBMI-DEI Committee Members
    • DBMI-DEI Resources
    • DBMI-DEI Committee Events
  1. University of Arkansas for Medical Sciences
  2. College of Medicine
  3. Department of Biomedical Informatics
  4. News
  5. 1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of NaV1.7 inhibition

1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of NaV1.7 inhibition

Bioorg Med Chem Lett. 2018 Jun 15;28(11):2103-2108. doi: 10.1016/j.bmcl.2018.04.035. Epub 2018 Apr 17

Boezio AA, Andrews K, Boezio C, Chu-Moyer M, Copeland KW, DiMauro EF, Foti RS, Fremeau RT Jr, Gao H, Geuns-Meyer S, Graceffa RF, Gunaydin H, Huang H, La DS, Ligutti J, Moyer BD, Peterson EA, Yu V, Weiss MM

Abstract

Recently, the identification of several classes of aryl sulfonamides and acyl sulfonamides that potently inhibit NaV1.7 and demonstrate high levels of selectivity over other NaV isoforms have been reported. The fully ionizable nature of these inhibitors has been shown to be an important part of the pharmacophore for the observed potency and isoform selectivity. The requirement of this functionality, however, has presented challenges associated with optimization toward inhibitors with drug-like properties and minimal off-target activity. In an effort to obviate these challenges, we set out to develop an orally bioavailable…

Read more: https://www.ncbi.nlm.nih.gov/pubmed/29709252

Posted by Chris Lesher on April 17, 2018

Filed Under: Publications Tagged With: Andrews K, Boezio AA, Boezio C, Chu-Moyer M, Copeland KW, DiMauro EF, Foti RS, Fremeau RT Jr, Gao H, Geuns-Meyer S, Graceffa RF, Gunaydin H, Huang H, La DS, Ligutti J, Moyer BD, Peterson EA, Weiss MM, Yu V

UAMS College of Medicine LogoUAMS College of MedicineUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2023 University of Arkansas for Medical Sciences